Pneumonia News and Research

Latest Pneumonia News and Research

Study finds nearly 50% decline in child mortality in Niger over the last decade

A study by researchers at the Johns Hopkins Bloomberg School of Public Health and the Niger Countdown Case Study Working Group found that child mortality in Niger-one of the world's poorest countries-declined nearly 50 percent over the last decade.

21 Sep 2012

Tight glycemic control does not reduce infection rate after pediatric cardiac surgery

Implementing tight glycemic control after surgery with cardiopulmonary bypass does not reduce the rate of healthcare-associated infections among pediatric patients, compared with standard care in the intensive care unit, show US study results.

20 Sep 2012

GSK3 inhibition protects against gum disease

Treatment with the cell-permeable glycogen synthase kinase -3β-specific enzyme inhibitor SB216763 successfully suppresses alveolar bone loss in mice infected with the main periodontal pathogen, Porphyromonas gingivalis, report researchers.

20 Sep 2012

Joint Commission offers ranking of hospitals on quality, patient safety

The hospital accreditation board recognized 620 hospitals as top performers based on 45 measures. The rankings reflect performance in 2011.

20 Sep 2012

Roundup: Ore. insurance CO-OP readies coverage; N.J. Medicaid liabilities hurt state's fiscal outlook; Wis. AG appeals collective bargaining ruling

Independent workers -- artists, journalists, information technology professionals, craftsmen and even those who earn their living buying and selling on eBay -- will soon have the ability to buy health coverage without having to dicker with a privately-run insurance company such as Regence BlueCross BlueShield. ... people can sign up when enrollment opens for the health insurance exchange in October 2013.

20 Sep 2012

Congress can help improve WASH, survival for children worldwide

David Winder, chief executive of WaterAid USA, highlights the findings of the recently released UNICEF report on child mortality in this Huffington Post "Impact" blog post, saying the decrease in annual number of child deaths "is great news, but is tempered by sobering statistics, especially for children in sub-Saharan Africa," who continue to face high rates of mortality.

19 Sep 2012

FDA designates Rib-X's delafloxacin as QIDP for acute bacterial skin and skin structure infections

Rib-X Pharmaceuticals, Inc., today announced that the Food and Drug Administration (FDA) designated delafloxacin as a Qualified Infectious Disease Product (QIDP) for the indications of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).

17 Sep 2012

Progress on child survival rate since 2000

The pace of reducing child deaths has accelerated sharply since 2000, according to new data released by UNICEF, the World Health Organization, the World Bank and the UN Population Division.

14 Sep 2012

Global child mortality rates fall 41% since 1990, U.N. reports

"Child mortality worldwide has fallen 41 percent since 1990, the result of myriad improvements in nutrition, access to vaccines and antibiotics, cleaner deliveries, better care of infants immediately after birth, and the use of insecticide-treated mosquito nets," according to "the findings of a report released Wednesday by three United Nations agencies and the World Bank," the Washington Post reports.

14 Sep 2012

Model predicts lung cancer risk

Researchers have shown that The Liverpool Lung Project Risk Model is effective in identifying those at the highest risk for lung cancer within 5 years, and who are therefore suitable for computed tomography screening.

13 Sep 2012

Alarm raised over preoperative hyponatremia

Preoperative hyponatremia is common and, even when mild, carries a risk for perioperative complications and mortality, shows a large cohort study.

12 Sep 2012

Gene therapy regimen can safely restore immune systems to children with Bubble Boy disease

UCLA stem cell researchers have found that a gene therapy regimen can safely restore immune systems to children with so-called "Bubble Boy" disease, a life threatening condition that if left untreated can be fatal within one to two years.

12 Sep 2012

Many pediatric respiratory hospitalizations unnecessary

Study findings suggest that a large number of pediatric hospitalizations, particularly those of a respiratory nature, could be prevented.

11 Sep 2012

Arsanis to develop monoclonal antibody therapeutics against nosocomial infections

Arsanis Biosciences GmbH, an early stage biotechnology company developing anti-infective human monoclonal antibodies, today announced the award of two major grants for the development of monoclonal antibody therapeutics against nosocomial infections.

11 Sep 2012

Pathogens identified in majority of childhood CAP hospitalizations

A comprehensive investigation of childhood community-acquired pneumonia in Taiwan has identified at least one pathogen in 85% of previously healthy children.

10 Sep 2012

Recent data from Silence Therapeutics’ Atu111 pre-clinical study on acute lung injury

Silence Therapeutics plc, a leading RNA interference (RNAi) therapeutics company is pleased to announce that recent data in pre-clinical models demonstrated the efficacy of Atu111 in acute lung injury.

10 Sep 2012

Tight blood sugar control does not benefit pediatric patients undergoing heart surgery

Although some studies have portrayed tight blood sugar control as a potential means of lowering infection rates in critically ill adults, a new study-led by principal investigator Michael Agus, MD, director of the Medicine Critical Care Program at Boston Children's Hospital-found no indication that the approach benefits pediatric patients undergoing heart surgery.

10 Sep 2012

Kalidex announces presentation of data on KPI-10 against MDR strains at ICAAC

Kalidex Pharmaceuticals, a privately-held anti-infective company, today announced the presentation of data on its lead development candidate KPI-10, a broad spectrum, next-generation fluoroquinolone, at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, September 9 through 12.

7 Sep 2012

Antibiotics: facts and fictions: an interview with Dr Philippa Binns, clinical adviser at NPS MedicineWise

Antibiotics are medicines used to treat infections or diseases caused by bacteria, such as some respiratory tract infections (including pneumonia and whooping cough), urinary tract infections, skin infections and infected wounds.

6 Sep 2012

Alnylam announces complete results from ALN-RSV01 Phase IIb trial on RSV infection

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today complete results from its Phase IIb trial with ALN-RSV01 for the treatment of respiratory syncytial virus (RSV) infection in lung transplant patients.

6 Sep 2012

Pneumonia News and Research

Latest Pneumonia News and Research

Study finds nearly 50% decline in child mortality in Niger over the last decade

Tight glycemic control does not reduce infection rate after pediatric cardiac surgery

GSK3 inhibition protects against gum disease

Joint Commission offers ranking of hospitals on quality, patient safety

Roundup: Ore. insurance CO-OP readies coverage; N.J. Medicaid liabilities hurt state's fiscal outlook; Wis. AG appeals collective bargaining ruling

Congress can help improve WASH, survival for children worldwide

FDA designates Rib-X's delafloxacin as QIDP for acute bacterial skin and skin structure infections

Progress on child survival rate since 2000

Global child mortality rates fall 41% since 1990, U.N. reports

Model predicts lung cancer risk

Alarm raised over preoperative hyponatremia

Gene therapy regimen can safely restore immune systems to children with Bubble Boy disease

Many pediatric respiratory hospitalizations unnecessary

Arsanis to develop monoclonal antibody therapeutics against nosocomial infections

Pathogens identified in majority of childhood CAP hospitalizations

Recent data from Silence Therapeutics’ Atu111 pre-clinical study on acute lung injury

Tight blood sugar control does not benefit pediatric patients undergoing heart surgery

Kalidex announces presentation of data on KPI-10 against MDR strains at ICAAC

Antibiotics: facts and fictions: an interview with Dr Philippa Binns, clinical adviser at NPS MedicineWise

Alnylam announces complete results from ALN-RSV01 Phase IIb trial on RSV infection

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Pneumonia News and Research

Latest Pneumonia News and Research

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Newsletters you may be interested in